COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03179943
Brief Title: Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma

First Submitted : June 6, 2017
First Submitted that Met QC Criteria : June 6, 2017
First Posted : June 7, 2017

Last Update Submitted that Met QC Criteria : August 17, 2020
Last Update Posted : August 19, 2020